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Edited by Judit Ova´diAbstract Scytalidoglutamic peptidase (SGP) is the ﬁrst-discov-
ered member of the eqolisin family of peptidases with a unique
structure and a presumed novel catalytic dyad (E136 and Q53)
[Fujinaga et al., PNAS 101 (2004) 3364–3369]. Mutants of
SGP, E136A, Q53A, and Q53E lost both the autoprocessing
and enzymatic activities of the wild-type enzyme. Coupled with
the results from the structural analysis of SGP, Glu136 and
Gln53 were identiﬁed as the catalytic residues. The substrate
speciﬁcity of SGP is unique, particularly, in the preference at
the P3 (basic amino acid), P
0
1 (small a.a.), and P
0
3 (basic a.a.)
positions. Superior substrates and inhibitors have been synthe-
sized for kinetic studies based on the results reported here. kcat,
Km, and kcat/Km of SGP for D-Dap(MeNHBz)-
GFKFF\ALRK(Dnp)-D-R-D-R were 34.8 s1, 0.065 lM, and
535 lM1 s1, respectively. Ki of Ac-FKF-(3S,4S)-phenylstati-
nyl-LR-NH2 for SGP was 1.2 · 1010 M. Taken together, we
can conclude that SGP has not only structural and catalytic nov-
elties but also a unique subsite structure.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Scytalidopepsin1. Introduction
In 1972, scytalidoglutamic peptidase (SGP) (formerly called
scytalidopepsin B) was discovered as a pepstatin-insensitive
carboxyl proteinase in the culture ﬁltrate of the wood-destroy-
ing fungus, Scytalidium lignicolum [1–3]. The enzyme is active
at acidic pH but it is insensitive to pepstatin. Since 1972, sev-
eral other pepstatin-insensitive carboxyl proteinases have been
found in bacteria and in fungi [4–6]. Among them, the tertiaryAbbreviations: FRETS, ﬂuorescence resonance energy transfer
substrate; MCA, peptidyl-4-methyl-coumaryl-7-amides; AMC, 7-
amino-4-methylcoumarin; Bz, benzoyl; MeNHBz, 2-(N-methylamino)-
benzoyl; Dap, D-2,3-diamino propionic acid; Dnp, 2,4-dinitrophenyl;
LC–MS, liquid chromatography mass spectrometer
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doi:10.1016/j.febslet.2005.04.050structure of Pseudomonas sp. carboxyl proteinase, sedolisin, a
typical bacterial enzyme, was determined in 2001 [7]. The en-
zyme has the subtilisin fold but with a unique catalytic triad,
Ser-Glu-Asp. Sedolisin and its family have now been classiﬁed
into the S53 peptidase family of serine peptidases in the MER-
OPS database [7,8].
In 2003, we solved the three-dimensional structure of SGP
and the results were published in 2004 [9]. The SGP molecule
is a b-sandwich structure composed of two 7-stranded anti-
parallel ß-sheets. This structure was the ﬁrst to be reported
among the known peptidases. In addition, the catalytic mech-
anism is unique. SGP was presumed to have a catalytic dyad of
Glu136 (E) and Gln53 (Q). The most likely hydrolytic mecha-
nism involves nucleophilic attack of a general base (Glu136)-
activated water (OH) on the si-face of the scissile peptide
carbonyl-carbon atom to form a tetrahedral intermediate.
Electrophilic assistance and oxyanion stabilization is provided
by the side-chain amide of Gln53. Protonation of the leaving-
group nitrogen is accomplished by the general acid function of
the protonated carboxy group of Glu136. Based on these un-
ique features, SGP has now been established as the sixth family
of peptidases, the glutamic peptidase (G1) family in the MER-
OPS database [8,9]. This family has been named the
eqolisins.
In order to clarify the structure–function relationships of
SGP, mutational analysis of the Glu136 and Gln53 residues,
which have been presumed to be the catalytic residues of
SGP, has been carried out. In addition, the substrate speciﬁcity
of SGP was investigated by using a novel type of FRET sub-
strates [10]. Based on the results obtained here, a highly sensi-
tive substrate for kinetic studies has been designed and
synthesized. Furthermore, a potent subnanomolar inhibitor,
useful for structural analysis, has also been synthesized.2. Materials and methods
2.1. Materials
A fragment corresponding to the SGP precursor gene was cloned
into expression vector pET15b (Novagen) using a PCR-based method
[11]. The resultant plasmid, pET15b/SLB was a generous gift from
Prof. Tsuru (Sojo University, Kumamoto, Japan). Enzymes used for
construction of the expression and mutation plasmids were purchased
from TOYOBO Co. (Osaka, Japan). Other reagents were purchased
from Wako Pure Chemicals (Osaka, Japan). FRET substrates and
the inhibitors were synthesized in the Peptide Institute, Inc. (Osaka
Japan).blished by Elsevier B.V. All rights reserved.
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A 0.7-kbp fragment of pET15b/SLB was ampliﬁed for the recombi-
nant SGP (wild-type) using a sense primer containing an EcoRI site 5 0-
CAT GAA TTC ATG AAG TTC ACT ACC GCT GCC-3 0 (S-1) and
an antisense primer containing a HindIII site 5 0-TAA AAG CTT TTA
AAC GTA AGA GCA GGA GAC-3 0 (AS-1). The expression plas-
mids for the SGP mutants were prepared by PCR-based mutagenesis.
The oligonucleotide primers (forward and reverse) used for mutagene-
sis have the following sequences; D43A: 5 0-GTT GGC ATT GCC
GGT GAT AC-3 0 and 5 0-ATC ACC GGC AAT GCC AAC CC-3 0;
Q53A, 5 0-CCA TCT TGG CAA CTG GTT TC-30 and 5 0-GAA
ACC AGT TGC CAA GAT GG-3 0; Q53E, 5 0-CCA TCT TGG
AAA CTG GTT TC-30 and 5 0-GAA ACC AGT TTC CAA GAT
GG-3 0; E136A, 5 0-TTC ATC ATC GCG GAC TTC GA-30 and 5 0-
GAA GTC CGC GAT GAT GAA CT-30. The ﬁrst PCR was carried
out using pET15b/SLB as a template and two sets of primers for each
mutant; one is a set of a primer S-1 and the reverse primer, and another
is a set of a primer AS-1 and the forward primer. The second PCR was
carried out using both of the ampliﬁed products as templates and a set
of primers S-1 and AS-1. Each ampliﬁed fragment was digested with
EcoRI and HindIII, and it was inserted into the EcoRI-HindIII site
of pKK223-3. Nucleotide sequences of all the expression plasmids
(pWT, pD43A, pQ53A, pQ53E, and pE136A) were determined and
veriﬁed correct.
2.3. Expression, refolding, and acid activation
Escherichia coli JM109 cells harboring the expression plasmids were
cultured at 30 C in 2 l of M9 medium containing 50 lg/ml of ampicil-
lin until absorbance at 660 nm = 0.6. Isopropyl-b-D-thiogalactopyra-
noside was added to a ﬁnal concentration of 1 mM and the growth
was continued for an additional 2 h. After disruption of the cells by
sonication, hydrochloric acid (1 N) was added to the suspension until
pH 5. The resultant precipitant was dissolved in 80 ml of a denatur-
ation buﬀer (8 M urea, 0.1 M ß-mercaptoethanol, 1 mM EDTA,
50 mM NaCl, 50 mM Tris–HCl, pH 8.0). After incubation for 1 h at
room temperature, ethanol was then added to a ﬁnal concentration
of 30%. After centrifugation at 48 000 · g for 30 min, the recombinant
protein was puriﬁed by DEAE-Sepharose CL-6B equilibrated with a
denaturation buﬀer. The eluate (0.2–0.3 M NaCl) was dialyzed against
each 20 times volume of 6, 4, or 2 M urea in PIPES buﬀer (50 mM
NaCl, 1 mM EDTA, 0.1 M PIPES-NaOH buﬀer, pH 6.5) for 2 h at
4 C. In addition, the sample was dialyzed against PIPES buﬀer over-
night at 4 C. In order to activate the expressed SGP, the resultant
solution was dialyzed against 100 times volume of 10 mM acetate buf-
fer, pH 4.0 at 4 C for 12 h. Detection of the expressed proteins was
performed by Western hybridization using a mouse anti-SGP
antibody.
2.4. Assay of peptidase activity and protein concentration
Enzyme activity was assayed at 37 C in 0.1 M acetate buﬀer, pH 4.0
containing 10 mM CaCl2 and 0.005% Triton X-100 using D-
Dap(MeNHBz)-GFKFF\ALRK(Dnp)-D-R-D-R (\, cleavage site) as
a substrate. Upon the cleavage of any peptide bond between D-
Dap(MeNHBz) and Lys(Dnp) in the substrate, the ﬂuorescence at
kex = 340 nm and kem = 440 nm increases in proportion to the release
of Nma ﬂuorophore from the internal Dnp quencher. Initial velocity
for hydrolysis was measured with 1 lM of the substrate. Protein con-
centration was estimated from the amino acid analysis of each sample.2.5. Substrate speciﬁcity
SGP used in this study was puriﬁed according to the method of Oda
et al. [1]. The FRETS-25Xaa libraries (D-Dap(MeNHBz)-G-Zaa-Yaa-
Xaa-A-F-P-K(Dnp)-D-R-D-R) used to study amino acid preference at
the P1 position, have been described previously [10]. Xaa represents the
ﬁxed position where each of the 19 natural amino acids excluding Cys
was incorporated. A mixture of ﬁve amino acids (P, Y, K, I, and D)
was incorporated at the Yaa position along with a mixture of ﬁve ami-
no acids (F, A, V, E, and R) at the Zaa position for each ﬁxed Xaa.
This provides a peptide mixture of 25 combination of each Xaa series
resulting in a combinatorial library with a total of 475 peptide sub-
strates in 19 separate pools.
FRETS-25F (D-Dap(MeNHBz)-G-Zaa-Yaa-F-A-F-P-K(Dnp)-D-R-
D-R) was used for analyzing the P2 and P3 preferences. Cleavage of the
substrate was monitored with increase of the ﬂuorescence intensity(kex = 340 nm and kem = 440 nm). Molecular weight of the cleaved
product was determined by LC–MS according to the previous report
[10]. Based on its molecular weight, the primary structure of the
cleaved product and cleavage site were identiﬁed.
For analyzing the primed-side preferences of eqolisin, three combi-
natorial libraries (D-Dap(MeNHBz)-GFKFF\Xaa-Yaa-Zaa-K(Dnp)-
D-R-D-R) were synthesized. Xaa, Yaa, and Zaa represent the ﬁxed po-
sition where each of the 19 natural amino acids excluding Cys was
incorporated (FRETS-19FP, Yaa and Zaa were ﬁxed by Phe and
Pro; FRETS-A19P, Xaa and Zaa were ﬁxed by Ala and Pro;
FRETS-AF19, Xaa and Yaa were ﬁxed by Ala and Phe).2.6. Kinetics assays
D-Dap(MeNHBz)-GFKFF\ALRK(Dnp)-D-R-D-R (sub-1) and D-
Dap(MeNHBz)-GFKFF\AFPK(Dnp)-D-R-D-R (sub-2) were synthe-
sized for kinetics study. The initial velocities were measured at several
diﬀerent concentrations of substrate at 37 C (100 mM acetate buﬀer
pH 4.0 containing 10 mM CaCl2 and 0.005% Triton X-100). Km and
Vmax were derived from the direct ﬁtting to the Michaelis–Menten
equation using a non-linear regression analysis program, with at least
ﬁve values of the initial substrate concentration used.2.7. Inhibition study
SGP (0.28 nM) was mixed with varying amounts of inhibitor (0–
1.63 nM) and incubated for 10 min at 37 C and pH 4.0. Because the
Ki value of the inhibitor was of the same order as the enzyme concen-
tration, we analyzed the inhibition according to the procedure de-
scribed by Tashiro et al. [12], and by Laskowski and Kato [13],
which have been widely used in the analysis of tightly-binding inhibi-
tors. Residual enzyme activity was estimated from the initial linear
part of ﬂuorescence intensity increase. The slopes were converted into
free enzyme concentrations together with the initial concentrations of
the inhibitor to calculate the association equilibrium constants, Ka (=1/
Ki), using personal software devised by Tashiro. Each titration curve
was ﬁtted to the theoretical equation of Bieth and Frechin [14] using
a non-linear least-squares analysis program. The best-ﬁt line through
the data points yielded Ka.3. Results and discussion
3.1. Identiﬁcation of catalytic dyad, Glu136 and Gln53
SGP is synthesized as a precursor protein consisting of a pre-
pro region (54 residues) and a mature region (206 residues)
[15]. The mature enzyme has signiﬁcant sequence similarity
to the other fungal carboxyl peptidases, Aspergillus niger car-
boxyl peptidase (ANCP), Sclerotinia sclerotiorum carboxyl
peptidase, Cryphonectria parasitica peptidases B and C, and
Talaromyces emersonii carboxyl peptidase [9].
We selected the residues Glu136, Gln53, and Asp43 for
mutational analysis. These residues are conserved in all of
the enzymes described above. Glu136 and Gln53 were identi-
ﬁed as the presumed catalytic residues by structural analysis
[9]. Asp43 which corresponds to the Asp53 in ANCP, had been
suggested as one of the catalytic residues by site-directed muta-
genesis of ANCP [16].
Wild-type SGP was expressed as a precursor form in E. coli.
After refolding, the precursor was autocatalytically converted
to the mature form under acidic conditions (Fig. 1). The ma-
ture enzyme showed normal peptidase activity. E136A,
Q53A, and Q53E mutants were expressed as precursor forms
in the same manner as the wild-type enzyme (Fig. 1). However,
none of the refolded precursors were converted to a mature
form under acidic conditions (Fig. 1). In addition, they did
not show any peptidase activity. These results strongly support
the contention that residues Glu136 and Gln53 are involved in
the catalytic function as predicted by James [9].
Table 1
Relative hydrolysis rate of eqolisin for FRET substrates
Position Amino acid residues Substrate
P3 Lys (100), Arg (35) FRETS-25F
P2 Phe (100), Tyr (39) FRETS-25F
P1 Phe (100), Tyr (90), His (40) FRETS-25Xaa
P01 Ala (100), Gly/Thr (88), Ser (75) FRETS-19FP
P02 Leu (100), Pro (79), Arg (75) FRETS-A19P
P03 Arg (100), Lys (81), His (74) FRETS-AF19







la-Phe-Xaa-Lys(Dnp)-D-Arg-D-Arg. \; cleavage site. Xaa represents the
ﬁxedpositionwhere eachof the19naturalaminoacids excludingCyswas
incorporated. A mixture of ﬁve amino acid residues (P, Y, K, I, and D)
was incorporated at the Yaa position along with a mixture of ﬁve amino
acid residues (F, A, V, E, and R) at the Zaa position.
Fig. 1. Western blot analysis of the recombinant eqolisin mutants. The
samples before (1) or after activation at pH 4.0 (2) were electrophoresis
in 12.5% SDS–polyacrylamide gel. They were analyzed by using a
mouse anti-eqolisin antibody. Lane A indicates authentic enzyme.
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lower molecular weight than that of wild-type (Fig. 1). The
precursor was autocatalytically converted to a mature form
under acidic condition. It showed about 20% of the activity
of that of the control. It has been clariﬁed based on the struc-
tural analysis that the Asp43 residue was buried in the core of
the SGP molecule and is essential to maintain the structure; it
is not one of the catalytic residues [9]. The truncated form of
the precursor in this case may be caused by its susceptibility
to endogenous E. coli proteinases. Coupled with the results
of the tertiary structure of SGP, it can be concluded that the
eqolisin family has a unique catalytic dyad composed of
Glu136 and Gln53 residues.
Quite recently, the three-dimensional structure of ANCP has
been elucidated [17]. Taken together with mutational analysis
[18], they have proposed the same catalytic mechanism as ours
[9].
3.2. Substrate speciﬁcity
FRETS-25Xaa libraries were used for the primary screening
of the P1 preference. SGP strongly preferred Phe and Tyr res-
idues at the P1 position (Fig. 2). Based on this ﬁrst result,
FRETS-25F (the P1 position of the substrate was ﬁxed by
Phe) was used for the secondary screening of the P2 and P3
preferences. D-Dap(MeNHBz)-GFKFF was identiﬁed as a
major cleavage product by LC–MS analysis. SGP preferen-
tially hydrolyzed substrate having Phe at the P2 position and
Lys at the P3 position (Table 1).
Thus, SGP prefers Phe and Tyr at the P1 position, Phe at the
P2 position, and Lys or Arg at the P3 position, respectively
(Fig. 2, Table 1). In contrast, porcine pepsin preferentially
hydrolyzed the peptides having Phe, Met, Leu, and Trp atFig. 2. P1 preference (the favored Xaa) using FRETS-25Xaa libraries.the P1 position, Glu, Asn, Ser, and Val at the P2 position,
and Ile, Ala, and Thr, but not Lys and Arg at the P3 position,
respectively [19]. These results suggest that the S1 and S2 sub-
sites of SGP may be large and hydrophobic in nature. In par-
ticular, the P3 preference of SGP is unique. SGP prefers a
positively charged residue, Lys or Arg at the P3 position, sug-
gesting that SGP may have one or more negatively charged
residue(s) in the S3 subsite.
In order to analyze the positional preferences of the primed-
side, a FRETS substrate, ﬁxed by Phe at the P1, Phe at the P2,
Lys, at the P3, and Phe at the P4 position, was used. FRETS-
19FP (the P02 and P
0
3 positions of substrate were ﬁxed by Phe
and Pro, respectively) was used for analyzing the P01 preference.
Based on the masses of the cleaved products, it was revealed
that SGP hydrolyzed substrates having Ala, Gly, Thr, and
Ser at the P01 position in descending order (Table 1). FRETS-
A19F (the P01 and P
0
3 positions of the substrate were ﬁxed by
Ala and Phe, respectively) and FRETS-AF19 (the P01 and P
0
2
positions of the substrate were ﬁxed by Ala and Phe, respec-
tively) were used for analyzing of the P02 and P
0
3 preferences,
respectively. SGP preferentially hydrolyzed the substrates hav-
ing Leu, Pro, and Arg at the P02 position, and Arg, Lys, and
His at the P03 position (Table 1).
Thus, SGP favored Ala, Gly, or Thr at the P01 position, sug-
gesting that the S01 subsite of SGP may be small (Table 1). In
contrast, porcine pepsin prefers large and hydrophobic resi-
dues (Tyr and Phe) at the P01 position [19]. The P
0
2 preference
of SGP was not strict (Table 1); SGP preferred a positively
charged residue, Arg or Lys at the P03 position (Table 1). Pepsin
preferred Val, Arg, Ala, and Glu at the P02 position and Leu
and Ile at the P03 position, respectively [19]. Taken together,




3 subsites are unique among
those proteinases having an optimum pH in the acidic range.
3.3. Kinetic studies
Two substrates (sub-1; D-Dap(MeNHBz)-GFKFF\ALRK
(Dnp)-D-R-D-R and sub-2; D-Dap(MeNHBz)-GFKFF\AFPK
(Dnp)-D-R-D-R) were synthesized for the kinetic studies. The







3 sites, while the sub-2 was designed to reﬂect
the preferences at the P3, P2, and P1 sites. kcat, Km, and kcat/Km
Fig. 3. Titration curve of the activity of eqolisin as a function of the
concentration of Ac-FKF(3S,4S)-Phenylstatinyl-LR-NH2.
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respectively (½E ¼ 37.1 pM, ½S ¼ 0.0713–1.14 lM). For
sub-2, kcat, Km, and kcat/Km were 11.3 s
1, 0.365 lM, and
31.0 lM1 s1, respectively (½E ¼ 32.3 pM, ½S ¼ 0.134–4.28
lM). kcat of sub-2 is three times lower than that of sub-1,
whereas Km of sub-2 is six times higher than that of sub-1.
Coupled with the results described above, it is clear that the
primed-side residues of substrates are also important for sub-
strate recognition and catalysis.3.4. Inhibition study
Two types of inhibitors were synthesized based on the
results described above. Ac-FKF(3S,4S)-phenylstatinyl-LR-
NH2 strongly inhibited peptidase activity of SGP with Ki of
1.2 · 1010 M (Fig. 3). In contrast, Ac-FKF(2R,3S)-phenyl-
isoseryl-ALR-NH2 did not show any inhibitory activity
against SGP. These results suggest that the steric orientation
of the scissile bond between P1 and P
0
1 is crucial for making
the enzyme-inhibitor complex.
In order to elucidate the catalytic function and biological
implications of SGP in detail, a three-dimensional structure
analysis of the SGP complex with the inhibitor is currently
underway.
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